Dr. Jonathan H. Soslow, MD
Pediatric Cardiology (Pediatric Cardiology Physician)
At a glance
- Medical school
- Louisiana State University School of Medicine in New Orleans (2003)
- Years since graduation
- 23
- In the NPI registry since
- 2006
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2003Medical school: Louisiana State University School of Medicine in New Orleans
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Pediatric Cardiology Physician primary
TN license 46170 · CA license A87917
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Vanderbilt University Medical Center Nashville, TN
Medical groups
- Vanderbilt University Medical Center (3,567 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Spironolactone Other prescribers in Nashville, TN | 21 |
| Lisinopril Other prescribers in Nashville, TN | 15 |
| Metoprolol Tartrate Other prescribers in Nashville, TN | 12 |
| Carvedilol Other prescribers in Nashville, TN | 11 |
| Qbrelis (lisinopril) Other prescribers in Nashville, TN | 11 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 3 companies reported 29 payments worth $84,374 in total to this clinician.
| Sarepta Therapeutics, Inc. | $74,259 |
|---|---|
| Ns Pharma, Inc. | $5,780 |
| Boehringer Ingelheim International GmbH | $4,335 |
| Consulting Fee | $59,590 |
|---|---|
| Travel and Lodging | $19,854 |
| Honoraria | $4,500 |
| Food and Beverage | $430 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Sarepta Therapeutics, Inc. Oct 20, 2025 | Consulting Fee | $19,780 |
| Sarepta Therapeutics, Inc. Oct 6, 2025 | Travel and Lodging Exondys 51 · Genetic Disease · travel to Vienna, Austria · in-kind | $15,589 |
| Sarepta Therapeutics, Inc. May 5, 2025 | Consulting Fee | $14,620 |
| Sarepta Therapeutics, Inc. Jul 9, 2025 | Consulting Fee | $11,180 |
| Sarepta Therapeutics, Inc. Aug 26, 2025 | Consulting Fee | $6,880 |
| Ns Pharma, Inc. Mar 20, 2025 | Honoraria VILTEPSO · PEDIATRIC NEUROLOGY | $4,500 |
| Boehringer Ingelheim International GmbH Sep 23, 2025 | Consulting Fee | $3,450 |
| Sarepta Therapeutics, Inc. Nov 25, 2025 | Consulting Fee | $1,720 |
| Sarepta Therapeutics, Inc. Dec 12, 2025 | Consulting Fee | $1,075 |
| Boehringer Ingelheim International GmbH Sep 16, 2025 | Consulting Fee | $885 |
All 21 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Sarepta Therapeutics, Inc. Dec 12, 2025 | Consulting Fee | $1,075 |
| Sarepta Therapeutics, Inc. Nov 25, 2025 | Consulting Fee | $1,720 |
| Sarepta Therapeutics, Inc. Oct 20, 2025 | Consulting Fee | $19,780 |
| Sarepta Therapeutics, Inc. Oct 6, 2025 | Travel and Lodging Exondys 51 · Genetic Disease · travel to Vienna, Austria · in-kind | $15,589 |
| Sarepta Therapeutics, Inc. Oct 6, 2025 | Travel and Lodging Exondys 51 · Genetic Disease · travel to Vienna, Austria · in-kind | $657 |
| Sarepta Therapeutics, Inc. Oct 6, 2025 | Travel and Lodging Exondys 51 · Genetic Disease · travel to Vienna, Austria · in-kind | $215 |
| Boehringer Ingelheim International GmbH Sep 23, 2025 | Consulting Fee | $3,450 |
| Boehringer Ingelheim International GmbH Sep 16, 2025 | Consulting Fee | $885 |
| Sarepta Therapeutics, Inc. Aug 26, 2025 | Consulting Fee | $6,880 |
| Sarepta Therapeutics, Inc. Jul 9, 2025 | Consulting Fee | $11,180 |
| Sarepta Therapeutics, Inc. Jun 14, 2025 | Travel and Lodging travel to Boston, MA · in-kind | $348 |
| Sarepta Therapeutics, Inc. Jun 14, 2025 | Travel and Lodging travel to Boston, MA · in-kind | $81.39 |
| Sarepta Therapeutics, Inc. Jun 13, 2025 | Travel and Lodging travel to Boston, MA · in-kind | $412 |
| Sarepta Therapeutics, Inc. Jun 13, 2025 | Travel and Lodging travel to Boston, MA · in-kind | $259 |
| Sarepta Therapeutics, Inc. May 5, 2025 | Consulting Fee | $14,620 |
| Sarepta Therapeutics, Inc. Apr 21, 2025 | Travel and Lodging travel to Boston, MA · in-kind | $226 |
| Ns Pharma, Inc. Mar 20, 2025 | Honoraria VILTEPSO · PEDIATRIC NEUROLOGY | $4,500 |
| Ns Pharma, Inc. Mar 7, 2025 | Travel and Lodging VILTEPSO · PEDIATRIC NEUROLOGY · travel to BASKING RIDGE, NJ | $809 |
| Ns Pharma, Inc. Mar 7, 2025 | Travel and Lodging VILTEPSO · PEDIATRIC NEUROLOGY · travel to BASKING RIDGE, NJ | $274 |
| Ns Pharma, Inc. Mar 7, 2025 | Travel and Lodging VILTEPSO · PEDIATRIC NEUROLOGY · travel to BASKING RIDGE, NJ | $197 |
| Sarepta Therapeutics, Inc. Feb 5, 2025 | Travel and Lodging travel to Cambridge, MA · in-kind | $787 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $1,100 in research payments for these studies, mostly to the institutions running them.
- Oral Ifetroban in Subjects With Duchenne Muscular Dystrophy
Cumberland Pharmaceuticals, Inc. · Completed · NCT03340675
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.